Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma: A pilot study

NuklearMedizin

Volumn 39, Issue 3, 2000, Pages 56-61

  Klein, Martine ^a   Freedman, N ^a   Lotem, M ^a   Marciano, R ^a   Moshe, S ^a   Gimon, Z ^a   Chisin, R ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

FDG; Lymphoscintigraphy; Melanoma; PET; Sentinel lymph node

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; METASTASIS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY;

EID: 0034111940     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632245     Document Type: Article

References (18)

1. Balch CM, Soong S-J, Shaw HM, et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Cutaneous melanoma. Balch CM, Houghton AN, Milton GW, et al. (eds). Lippincott. Philadelphia 1992; 165-87.
2. Breslow A. Thickness, cross-sectional areas and depth of melanoma in the prognosis of cutaneous melanoma. Ann Surg 1970; 72: 902.
3. Gershenwald J, Thompson W, Mansfield P, et al. Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. Society of Surgical Oncology 1996 (abstract) Atlanta. GA, March 21-24, 1996.
4. Holder WD Jr, White RL Jr, Zuger JH, et al. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998; 227: 764-71.
5. Ketcham AS, Moffatt FL, Balch CM. Classification and staging. In: Cutaneous melanoma. Balch CM, Houghton AN, Milton GW et al. (eds). Lippincott, Philadelphia 1992; 21-220.
6. Melanoma. Cancer statistics and epidemiology. Israeli Ministry of Health. Jerusalem, Israel, 1999.
7. Milton GW, Show HM, Mc Cathy WH, et al. Proplylactic lymph node dissection in clinical stage I cutaneous melanoma: results of surgical treatment of 319 patients.
8. Br J Surg 1982; 196: 677-84.
9. Morton DC, Wen DR, Cochran AJ. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lympha-denectomy or ìwatch and waiti. Surg Oncol Clin North Am. 1992; 1: 247-59.
10. Norman J, Cruse CW. Espinos C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigaphy for malignant melanoma .Am J Surg 1991; 162: 432-7
11. Norman J, Wells K, Kearney R, et al. Identification of lymphatic drainage patterns in patients with cutaneous melanoma. Sem Surg Oncol 1993; 9:224-7.
12. Reintgen DS, Albertini J, Berman C, et al. Accurate nodal staging of malignant melanoma. Cancer Control J Moffitt Cancer Center 1995; 2: 405-14.
13. Reintgen DS, Einstein A. The role of research in cost containment. Cancer Control J Moffit Cancer Center 1995; 2: 429-31.
14. Rinne D, Baum RP, Hor G, et al. Primary staging and follow-up of high risk melanoma patients with whole body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998; 82: 1664-71.
15. Singluff CL, Stidham KR, Ricci WB, et al. Surgical management of regional lymph nodes in patients with melanoma. Ann Surg 1994; 219: 120-30.
16. Steinert HC, Boni RAH, Buck A, et al. Malignant melanoma: staging with whole body positron emission tomography using 18FDG. Radiology 1995; 195: 705-9.
17. Wagner JD, Schauwecker D, Davidson D et al. Pro-spective study of fluorodeoxyglucose positron emission tomography imaging of lymph node basin in melanoma patients undergoing sentinel node biopsy. J Clin One 1999; 17: 1508-15.
18. Wagner JD, Schauwecker D, Hutchins G et al. Initial assessment of positron emission tomography for detection of non palpable regional lymphatic metastases in melanoma. J Surg Oncol 1997; 64: 181-9.